Healthcare - Medical - Devices - NASDAQ - US
$ 0.8849
-0.461 %
$ 64.3 M
Market Cap
-1.47
P/E
CASH FLOW STATEMENT
-41.8 M
OPERATING CASH FLOW
-804 K
INVESTING CASH FLOW
174 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Hyperfine, Inc.
| Net Income | -44.2 M |
| Depreciation & Amortization | 1.05 M |
| Capital Expenditures | -804 K |
| Stock-Based Compensation | 4.74 M |
| Change in Working Capital | -3.62 M |
| Others | -116 K |
| Free Cash Flow | -42.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (44.2) | (73.2) | (64.9) | (23.4) | (19.4) |
| Depreciation & Amortization | 1.1 | 1.0 | 0.7 | 0.3 | 0.1 |
| Deferred Income Tax | 0 | 0 | 1.1 | 0.2 | 0 |
| Stock Based Compensation | 4.7 | 10.7 | 6.9 | 1.1 | 0.9 |
| Other Operating Activities | 0.2 | 91 K | 10 K | 44 K | 4 K |
| Change in Working Capital | (3.6) | (10.9) | 9.0 | 0.3 | 2 K |
| Cash From Operations | (41.8) | (72.3) | (47.2) | (21.5) | (18.4) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (0.8) | (0.6) | (2.7) | (1.6) | (0.2) |
| Other Items | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.8) | (0.6) | (2.7) | (1.6) | (0.2) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | (0.2) | 0.2 | (1.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.2 | 7 K | 176.9 | 60.8 | 5.7 |
| Cash From Financing Activities | 0.2 | 7 K | 176.8 | 60.9 | 4.7 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (42.4) | (72.9) | 126.9 | 37.8 | (13.9) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (42.6) | (72.9) | (49.9) | (23.1) | (18.6) |